Brugada syndrome and anesthesia

Brugada sendromu, yapısal kalp hastalığı bulunmayanlarda, elektrokardiyografide V1-3 derivasyonlarında sağ dal bloku ile spontan ya da indüklenmiş ST-segment elevasyonu ile karakterize, ani kardiyak ölüme yol açan genetik bir hastalıktır. Brugada sendromu bulunan hastalarda anestezi uygulamasına ilişkin sınırlı sayıda deneyim mevcut olduğu için, klinik uygulamaya yönelik henüz bir uzlaşı raporu bulunmamaktadır. Bu sistematik derlemede nadir görülen bu kalp hastalığında uygulanan anestezi teknikleri ve anesteziklerin etkileri ve güvenliliği irdelendi.

Brugada sendromu ve anestezi

Brugada syndrome is a genetic disease leading to sudden cardiac death, which is characterized by a spontaneous or induced ST-segment elevation with right bundle branch block in V1-3 leads in electrocardiography in those without any structural heart disease. As there is a limited number of experiences on anesthetizing patients with Brugada syndrome, no consensus report for clinical practice has been available yet. In this systematic review, we discussed the anesthesia techniques, and the effects and safety of anesthesia applied in this rarely seen heart disease.

PDF

___

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
2. Berne P, Brugada J. Brugada syndrome 2012. Circ J 2012;76:1563-71.
3. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-6.
4. Brugada P, Benito B, Brugada R, Brugada J. Brugada syndrome: update 2009. Hellenic J Cardiol 2009;50:352-72.
5. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
6. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106:2514-9.
7. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70.
8. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-600.
9. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006;29:1130-59.
10. Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005;2:254-60.
11. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006;17:857-64.
12. Joshi S, Raiszadeh F, Pierce W, Steinberg JS. Antiarrhythmic induced electrical storm in Brugada syndrome: a case report. Ann Noninvasive Electrocardiol 2007;12:274-8.
13. Takagi M, Doi A, Takeuchi K, Yoshikawa J. Pilsicanide- induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:837.
14. Tatlı E, Gül Ç, Sürücü H, Özçelik F. Brugada sendromunda tanı, klinik seyir ve tedavi yaklaşımı. Turkiye Klinikleri J Med Sci 2005;25:560-4.
15. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-484.
16. Schweizer PA, Becker R, Katus HA, Thomas D. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/ quinidine. Clin Res Cardiol 2010;99:467-70. doi: 10.1007/ s00392-010-0145-7.
17. Sumi S, Maruyama S, Shiga Y, Kodama S, Miyoshi K, Tojou H, et al. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2010;33:e53-6. doi: 10.1111/j.1540-8159.2009.02665.x.
18. Kyriazis K, Bahlmann E, van der Schalk H, Kuck KH. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram. Europace 2009;11:665-6. doi: 10.1093/ europace/eup070.
19. Wettwer E, Himmel HM, Amos GJ, Li Q, Metzger F, Ravens U. Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes. Br J Pharmacol 1998;125:659-66.
20. Abud A, Bagattin D, Goyeneche R, Becker C. Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2006;17:210-2.
21. Fish JM, Welchons DR, Kim YS, Lee SH, Ho WK, Antzelevitch C. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 2006;113:1393-400.
22. Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to- date website (www.brugadadrugs.org). Heart Rhythm 2009;6:1335-41. doi: 10.1016/j.hrthm.2009.07.002.
23. Schmidt J, Hering W, Albrecht S. Total intravenous anesthesia with propofol and remifentanil. Results of a multicenter study of 6,161 patients. Anaesthesist 2005;54:17-28. [Abstract]
24. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia 2007;62:690-701.
25. Fudickar A, Bein B, Tonner PH. Propofol infusion syndrome in anaesthesia and intensive care medicine. Curr Opin Anaesthesiol 2006;19:404-10.
26. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta- analyses: the PRISMA statement. BMJ 2009;339:b2535. doi: 10.1136/bmj.b2535.
27. Kloesel B, Ackerman MJ, Sprung J, Narr BJ, Weingarten TN. Anesthetic management of patients with Brugada syndrome: a case series and literature review. Can J Anaesth 2011;58:824-36. doi: 10.1007/s12630-011-9546-y.
28. Santambrogio LG, Mencherini S, Fuardo M, Caramella F, Braschi A. The surgical patient with Brugada syndrome: a four-case clinical experience. Anesth Analg 2005;100:1263-6.
29. Inamura M, Okamoto H, Kuroiwa M, Hoka S. General anesthesia for patients with Brugada syndrome. A report of six cases. Can J Anaesth 2005;52:409-12.
30. Tsutsumi YM, Tomiyama Y, Horikawa YT, Sakai Y, Ohshita N, Tanaka K, et al. General anesthesia for electroconvulsive therapy with Brugada electrocardiograph pattern. J Med Invest 2011;58:273-6.
31. Candiotti KA, Mehta V. Perioperative approach to a patient with Brugada syndrome. J Clin Anesth 2004;16:529-32.
32. Fuyuta M, Nakao S, Takai N, Shiba M, Tanaka Y, Iwamoto T, et al. Sudden Cardiac Arrest During General Anesthesia in an Undiagnosed Brugada Patient. J Cardiothorac Vasc Anesth 2012. pii: S1053-0770(12)00419-3. doi: 10.1053/j. jvca.2012.08.007. [Epub ahead of print]
33. Phillips N, Priestley M, Denniss AR, Uther JB. Brugada- type electrocardiographic pattern induced by epidural bupivacaine. Anesth Analg 2003;97:264-7.
34. Kapoor-Katari K, Neustein SM. General anesthesia for a patient with Brugada syndrome. Middle East J Anesthesiol 2012;21:743-6.
35. Fujiwara Y, Shibata Y, Kurokawa S, Satou Y, Komatsu T. Ventricular tachycardia in a patient with Brugada syndrome during general anesthesia combined with thoracic paravertebral block. Anesth Analg 2006;102:1590-1.
36. Konishi J, Suzuki T, Kondo Y, Baba M, Ogawa S. Rocuronium and sugammadex used effectively for electroconvulsive therapy in a patient with Brugada syndrome. J ECT 2012;28:e21-2. doi: 10.1097/YCT.0b013e31824b74f5.
37. Goraksha S, Bidaye S, Gajendragadkar S, Bapat J, Butani M. General anaesthesia for insertion of an automated implantable cardioverter defibrillator in a child with Brugada and autism. Indian J Anaesth 2010;54:562-4. doi: 10.4103/0019-5049.72648.
38. Vaccarella A, Vitale P, Presti CA. General anaesthesia in a patient affected by Brugada syndrome. Minerva Anestesiol 2008;74:149-52.
39. Richter S, Brugada P. Propofol-induced coved-type electrocardiogram during catheter ablation of paroxysmal atrial fibrillation. A case of Brugada syndrome? Herzschrittmacherther Elektrophysiol 2012;23:56-8. doi: 10.1007/s00399-011-0156-8.
40. Vernooy K, Sicouri S, Dumaine R, Hong K, Oliva A, Burashnikov E, et al. Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Heart Rhythm 2006;3:1074-8.
41. Baty L, Hollister J, Tobias JD. Perioperative management of a 7-year-old child with Brugada syndrome. J Intensive Care Med 2008;23:210-4. doi: 10.1177/0885066608315823.
42. Horigome H, Shigeta O, Kuga K, Isobe T, Sakakibara Y, Yamaguchi I, et al. Ventricular fibrillation during anesthesia in association with J waves in the left precordial leads in a child with coarctation of the aorta. J Electrocardiol 2003;36:339-43.
43. Canbay O, Erden IA, Celebi N, Aycan IO, Karagoz AH, Aypar U. Anesthetic management of a patient with Brugada syndrome. Paediatr Anaesth 2007;17:1225-7.
44. Enting D, Ligtenberg JJ, Aarts LP, Zijlstra JG. Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome: a fatal common pathway? Anesth Analg 2005;100:1864-5.
45. Edge CJ, Blackman DJ, Gupta K, Sainsbury M. General anaesthesia in a patient with Brugada syndrome. Br J Anaesth 2002;89:788-91.
46. Kim JS, Park SY, Min SK, Kim JH, Lee SY, Moon BK, Chae YJ. Anaesthesia in patients with Brugada syndrome. Acta Anaesthesiol Scand 2004;48:1058-61.
47. Lopez-Jinemez FA, Mondragon-Villanueva ME. Brugada syndrome and anesthesia. Rev Mex Anesthesiol 2008;31:54-61.
48. Cordery R, Lambiase P, Lowe M, Ashley E. Brugada syndrome and anesthetic management. J Cardiothorac Vasc Anesth 2006;20:407-13.
49. Kaneda Y, Fujita N, Ueda K, Saeki K, Sakano H, Sudo M, et al. Surgically treated primary lung cancer associated with Brugada syndrome: report of a case. Surg Today 2001;31:817-9
50. Chan TM, Dob DP. The anaesthetic management of a parturient with polymorphic catecholamine-sensitive ventricular tachycardia. Int J Obstet Anesth 2002;11:122-4.
51. Cole JB, Sattiraju S, Bilden EF, Asinger RW, Bertog SC. Isolated tramadol overdose associated with Brugada ECG pattern. Pacing Clin Electrophysiol 2012;35:e219-21. doi: 10.1111/j.1540-8159.2010.02924.x.
52. Haeseler G, Foadi N, Ahrens J, Dengler R, Hecker H, Leuwer M. Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain 2006;126:234-44.
53. Bramall J, Combeer A, Springett J, Wendler R. Caesarean section for twin pregnancy in a parturient with Brugada syndrome. Int J Obstet Anesth 2011;20:181-4. doi: 10.1016/j. ijoa.2010.10.006.
54. Hayashida H, Miyauchi Y. Anaesthetic management in patients with high-risk Brugada syndrome. Br J Anaesth 2006;97:118-9.
55. Ebert TJ, Lindenbaum L. Clinical pharmacology of inhaled anesthetics. In: Evers AS, Maze M, Kharasch ED, editors. Anesthetic pharmacology. Cambridge. Cambridge University Press; 2011. p. 317-419.
56. Sear JW. Clinical pharmacology of intravenous anesthetics. In: Evers AS, Maze M, Kharasch ED, editors. Anesthetic pharmacology. Cambridge. Cambridge University Press; 2011. p. 444-65.
57. Drugs preferably avoided by Brugada syndrome patients Avaible from: http://www.brugadadrugs.org/ [Accessed: December 10, 2012].
58. Barajas-Martínez HM, Hu D, Cordeiro JM, Wu Y, Kovacs RJ, Meltser H, et al. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Circ Res 2008;103:396-404. doi: 10.1161/ CIRCRESAHA.108.172619.
59. Rollin A, Maury P, Guilbeau-Frugier C, Brugada J. Transient ST elevation after ketamine intoxication: a new cause of acquired brugada ECG pattern. J Cardiovasc Electrophysiol 2011;22:91-4. doi: 10.1111/j.1540-8167.2010.01766.x.
60. Kawaguchi Y, Kushikata T, Hashiba E, Kitayama M, Yoshida H, Ishihara H, et al. Anesthetic management for patients with Brugada syndrome. Masui 2006;55:142-9. [Abstract]
61. Kohda K, Sugano T, Shibama S, Harada M, Satoh Y, Ide Y, et al. Preoperative evaluation and anesthetic management of a patient with Brugada syndrome-like ECG. Masui 2007;56:1398-403. [Abstract]
62. Yatabe T, Hirohashi M, Takeuchi S, Maeda Y, Yamashita K, Yokoyama M. Case of ventricular fibrillation in patients with brugada type electrocardiogram during surgery. Masui 2011;60:728-32. [Abstract]
63. Hiuge Y, Ohta N, Hirata T, Mori T. Anesthetic management of two patients with Brugada-type ECG and of different clinical severity. Masui 2004;53:693-5. [Abstract]
64. Vernooy K, Delhaas T, Cremer OL, Di Diego JM, Oliva A, Timmermans C, et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm 2006;3:131-7.
65. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-7.